Figure 6From: Selective inhibition of liver X receptor α-mediated lipogenesis in primary hepatocytes by licochalcone ASchematic diagram of selective inhibition of lipogenic pathway by LicA. Combination therapy of LicA and T0901317 could improve atherosclerosis without lipogenic adverse effects.Back to article page
